This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
In this Pharmaceutical Executive article, Kristen Backor expands on the results of a CRA study which found that more than half of healthcare providers have changed prescribing decisions in some way as a result of the coronavirus.
As Dr. Backor explains, “These data reflect changes in physician management as a result of the COVID-19 pandemic, and these changes are likely to have an impact into 2021 and beyond.”
she/her/hers
Vice President and Director of the Market Research Center of Excellence
College Station
San Francisco
+1-512-915-8757 kbackor@crai.comIntroduction and how the sampling industry works The landscape of market research sampling has had to evolve significantly in recent years. AI-driven bots are...
Access to medicine and healthcare services poses persistent challenges, especially in low-income regions with high out-of-pocket expenses. Pharmaceutical...
